[The biotransformation of STS 267 [16 alpha-azido-3-methoxyestra-1,3,5(10)-triene-17-one]. Epimerization of a 16 alpha-azido group--a new metabolic reaction in the rat liver].
STS 267 [1; 16 alpha-azido-3-methoxy-estra-1,3,5(10)-trien-17-one] was found to have lipid shifting and fertility inhibitory effects in rats. In preclinical studies the metabolic fate of 1 was investigated in the rat. Demethylation in 3-position, reduction of the 17-carbonyl to the 17 beta-hydroxyl group, and for the first time the epimerization of the 16 alpha-azido to the 16 beta-azido group were established following perfusion of STS 267 in the isolated rat liver. From the perfusion medium 16 alpha-azido-estra-1,3,5(10)-trien-3-ol-17-one (2), 16 alpha-azido-estra-1,3,5(10)-trien-3,17 beta-diol (3), 16 beta-azido-3-methoxy-estra-1,3,5(10)-trien-3,17 beta-diol (4) and 16 beta-azido-estra-1,3,5(10)-trien-3,17 beta-diol (5) as the main metabolite were isolated by TLC and identified by comparison with authentic samples. The extent of the hepatic extraction of 1 in the rat liver was significant lower compared with mestranol.